Pharmacogenomics: Shaping Prescribing

Publication Date

Spring 4-30-2014

Document Type

Article

Disciplines

Family Practice Nursing | Genetic Phenomena | Geriatric Nursing | Neurosciences | Primary Care | Psychiatric and Mental Health Nursing | Psychiatry

Abstract

Is there a way for nurse practitioners to personalize psychopharmacologic interventions that would reduce the treatment burden of the standard medication trial?

In the traditional psychiatric encounter, the patient reports symptoms and the clinician observes signs and formulates a diagnosis that will be the focus of a pharmacologic intervention.

When the desired outcome is not achieved, the medication is changed until it is achieved. With each medication trial, the patient is subject to potential adverse drug reactions and ineffective therapy. In certain instances, adverse drug reactions may be lethal. Furthermore, patient adherence to medication is known to be problematic

Share

COinS